GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (TSE:4519) » Definitions » Price-to-Free-Cash-Flow

Chugai Pharmaceutical Co (TSE:4519) Price-to-Free-Cash-Flow : 24.72 (As of Apr. 25, 2024)


View and export this data going back to 1956. Start your Free Trial

What is Chugai Pharmaceutical Co Price-to-Free-Cash-Flow?

As of today (2024-04-25), Chugai Pharmaceutical Co's share price is 円4860.00. Chugai Pharmaceutical Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円196.59. Hence, Chugai Pharmaceutical Co's Price-to-Free-Cash-Flow Ratio for today is 24.72.

The historical rank and industry rank for Chugai Pharmaceutical Co's Price-to-Free-Cash-Flow or its related term are showing as below:

TSE:4519' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 16.53   Med: 46.02   Max: 3125
Current: 23.82

During the past 13 years, Chugai Pharmaceutical Co's highest Price-to-Free-Cash-Flow Ratio was 3125.00. The lowest was 16.53. And the median was 46.02.

TSE:4519's Price-to-Free-Cash-Flow is ranked worse than
55.67% of 494 companies
in the Drug Manufacturers industry
Industry Median: 21.73 vs TSE:4519: 23.82

Chugai Pharmaceutical Co's Free Cash Flow per Share for the three months ended in Dec. 2023 was 円64.42. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was 円196.59.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Chugai Pharmaceutical Co was 94.80% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 32.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 38.20% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 36.20% per year.

During the past 13 years, Chugai Pharmaceutical Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 294.50% per year. The lowest was -60.60% per year. And the median was 5.80% per year.


Chugai Pharmaceutical Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Chugai Pharmaceutical Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Price-to-Free-Cash-Flow Chart

Chugai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.99 63.03 29.72 32.15 26.19

Chugai Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.68 36.33 39.90 26.19 -

Competitive Comparison of Chugai Pharmaceutical Co's Price-to-Free-Cash-Flow

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Price-to-Free-Cash-Flow falls into.



Chugai Pharmaceutical Co Price-to-Free-Cash-Flow Calculation

Chugai Pharmaceutical Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=4860.00/196.587
=24.72

Chugai Pharmaceutical Co's Share Price of today is 円4860.00.
Chugai Pharmaceutical Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円196.59.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Chugai Pharmaceutical Co  (TSE:4519) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Chugai Pharmaceutical Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Chugai Pharmaceutical Co (TSE:4519) Business Description

Traded in Other Exchanges
Address
1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding Ltd, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and COVID-19.

Chugai Pharmaceutical Co (TSE:4519) Headlines

No Headlines